An Evidence-Based Guideline on the Application of Molecular Testing in the Diagnosis, Prediction of Prognosis, and Selection of Therapy in Non-GIST Soft Tissue Sarcomas

Soft tissue sarcomas (STS) are malignant tumours originating from the cells of the connective and supporting tissues [1]. More than 50 types of STS can arise in any location of the body with different pathological and clinical presentations [1]. The histological features of these tumours are frequently subtle and accurate classification by light microscopy and immunohistochemistry alone can occasionally be challenging for pathologists, particularly in the context of limited sampling (e.g., needle core biopsy).

Source: Cancer Treatment Reviews - February 13, 2020 Category: Cancer & Oncology Authors: Xiaomei Yao, Michelle Ghert, Brendan C. Dickson, Snezana Popovic, Bibianna M. Purgina, Shailendra Verma, Joel Werier, Rita A. Kandel Tags: Systematic or Meta-analysis Studies Source Type: research